These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 976576)

  • 41. The intra-amniotic administration of prostaglandin f-2-alpha with intravenous oxytocin for the induction of midtrimester abortion.
    Laitinen S; Pystynen P
    Ann Chir Gynaecol Fenn; 1974; 63(1):35-8. PubMed ID: 4832154
    [No Abstract]   [Full Text] [Related]  

  • 42. Induction of abortion by extraamniotic administration of prostaglandin F2alpha. (A preliminary report).
    Hingorani V; Ganesh K
    Adv Biosci; 1973; 9():665-8. PubMed ID: 4805877
    [No Abstract]   [Full Text] [Related]  

  • 43. Uterine rupture as a complication of second-trimester abortion when using prostaglandin F2 alpha together with other oxytocic agents.
    Malmström H; Hemmingsson E
    Acta Obstet Gynecol Scand; 1984; 63(3):271-2. PubMed ID: 6587739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of prostaglandin F2alpha in abortion.
    Wolf JA; Rubinstein LM
    Am J Obstet Gynecol; 1977 Dec; 129(8):928-9. PubMed ID: 930986
    [No Abstract]   [Full Text] [Related]  

  • 45. Failed prostaglandin F2alpha-induced abortion: a case report.
    Cunanan RG; Castilone HC; Reyes MZ
    Obstet Gynecol; 1977 Apr; 49(4):495-6. PubMed ID: 854252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abortion-inducing effect of prostaglandin F2-alpha in the mid-trimester of pregnancy.
    Pajor A; Zsolnai B
    Acta Chir Hung; 1984; 25(4):229-38. PubMed ID: 6596819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of combination prostaglandin F2alpha and hypertonic saline for midtrimester abortion.
    Borten M
    Prostaglandins; 1976 Oct; 12(4):625-30. PubMed ID: 973007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of abortion by prostaglandins in the second trimester of pregnancy. A review.
    Kajanoja P
    Acta Obstet Gynecol Scand Suppl; 1983; 113():145-51. PubMed ID: 6574670
    [No Abstract]   [Full Text] [Related]  

  • 49. [Induction of therapeutic abortion by intra-amniotic and intravenous administration of prostaglandin F2-alpha in the second trimester of pregnancy].
    Otoka A; Otoka K
    Wiad Lek; 1982 Sep; 35(15-16):969-72. PubMed ID: 6959421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prostaglandin F2alpha as a method of choice for interruption of pregnancy (author's transl)].
    Zahn V; Johannigmann J
    Geburtshilfe Frauenheilkd; 1975 Mar; 35(3):203-10. PubMed ID: 1055706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Theraupeutic intra-amniotic, transabdominal induction of abortion in the 2nd trimenon using prostaglandin F 2alpha].
    Sacha E; Gigon U; Dreher E; Jann FX
    Gynakol Rundsch; 1976; 16(4):261-3. PubMed ID: 1035876
    [No Abstract]   [Full Text] [Related]  

  • 52. Therapeutic abortion by intraamniotic injection of prostaglandins.
    Roberts G; Gomersall R; Adams M; Turnbull AC
    Adv Biosci; 1973; 9():555-60. PubMed ID: 4805868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Midtrimester abortion induced by hyperosmolar urea and prostaglandin F2 alpha in patients with previous cesarean section: clinical course and potential for uterine rupture.
    Atienza MF; Burkman RT; King TM
    Am J Obstet Gynecol; 1980 Sep; 138(1):55-9. PubMed ID: 7416206
    [No Abstract]   [Full Text] [Related]  

  • 54. Interruption of pregnancy by PGF2 alpha. I. Intraamniotic administration.
    Szontágh FE; Szabó E; Tekulics A; Kovács I
    Acta Eur Fertil; 1972 Dec; 3(4):363-72. PubMed ID: 4679685
    [No Abstract]   [Full Text] [Related]  

  • 55. Investigation of prostaglandins for abortion.
    Lauersen NH
    Acta Obstet Gynecol Scand Suppl; 1979; 81():1-36. PubMed ID: 377889
    [No Abstract]   [Full Text] [Related]  

  • 56. Electroencephalographic changes following intraamniotic prostaglandin F2 alpha administration for therapeutic abortion.
    Faden A; Golbus M; Spire JP
    Obstet Gynecol; 1976 May; 47(5):607-8. PubMed ID: 1264408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Introduction of second trimester abortions with 15-(S)-methyl prostaglandin F2alpha by intra-uterine and intramuscular routes.
    Hingorani V; Agarwal N; Bhadury R; Singh CM; Baliga N; Tekumalla L
    J Indian Med Assoc; 1976 Jun; 66(11):279-83. PubMed ID: 977973
    [No Abstract]   [Full Text] [Related]  

  • 58. Midtrimester abortion procedures.
    Cates W; Schulz KF; Grimes DA
    Am J Obstet Gynecol; 1979 Apr; 133(8):934-7. PubMed ID: 434042
    [No Abstract]   [Full Text] [Related]  

  • 59. The synergistic activity of intra-amniotic prostaglandin F2 alpha and urea in the midtrimester elective abortion.
    King TM; Atienza MF; Burkman RT; Burnett LS; Bell WR
    Am J Obstet Gynecol; 1974 Nov; 120(5):704-18. PubMed ID: 4609151
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of extra-amniotic administration of PGF2alpha, 0.9 per cent saline, and 20 per cent saline followed by oxytocin for therapeutic abortion.
    Lange AP; Secher NJ; Pedersen GT
    Acta Obstet Gynecol Scand Suppl; 1974; 37():61-6. PubMed ID: 4533700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.